Abortion
-
EXCLUSIVE: Terán secures coveted endorsement from youth climate group
Sunrise Movement helped form the Biden-Harris administration’s climate policy and holds significant sway with Millennial and Gen Z voters.
-
Arizona abortion ballot measure locks in more than twice the number of signatures needed
Supporters of the Arizona Abortion Access Act delivered over 800,000 signatures for the ballot measure to the Secretary of State’s Office on July 3.
-
Kamala Harris’ fight for reproductive freedom takes center stage in 2024
In the two years since the US Supreme Court overturned Roe v. Wade, Vice President Kamala Harris has become a strong, passionate voice for reproductive rights.
-
Rep. Judy Schwiebert talks education, family, and what it takes to change the system
North Valley residents: Bookmark this exclusive Q&A with Rep. Schwiebert, part of The Copper Courier’s guide to voting in the 2024 election.
-
Gallego campaign leans into courting Latino voters
The US Senate candidate is one of only a handful of campaigns investing heavily in Spanish-language ads and hosting family-friendly events in Latino communities.
-
This Arizona ballot measure would take major judicial elections away from voters
SCR 1044 appears to be a way to protect the Arizona Supreme Court justices who ruled to reinstate the 1864 total abortion ban.
-
GOP lawmakers bypass Hobbs to add 11 measures to ballot. What to look out for
Voters will be asked to weigh in on laws that would make school board races partisan, end term limits for judges, and lower the minimum wage for tipped workers, among other things.
-
VIDEO: How to keep contraceptives legal in Arizona
The Arizona GOP controls both chambers of the state Legislature. Why didn’t they give a bill to protect contraceptives a hearing?
-
Supreme Court rejects bid to restrict abortion pill access, but leaves door open for future challenges
Justice Brett Kavanaugh, writing on behalf of the Supreme Court, wrote that while the plaintiffs did not have standing to sue over the FDA’s regulation of mifepristone, “it is not clear that no one else would have standing to challenge the FDA’s relaxed regulation of mifepristone.”
























